omeprazole and thiophenes

omeprazole has been researched along with thiophenes in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (50.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adami, M; Bertaccini, G; Coruzzi, G; Di Stilo, A; Gasco, A; Gili, M; Sorba, G	1
Bickel, M; Herling, AW; Lang, HJ; Rippel, R; Scheunemann, KH; Scholl, T; Weidmann, K	1
Beil, W; Sewing, KF; Staar, U	1
Hussar, DA	1
Cantor, LB	1
Kim, JW; Lee, DY; Lee, MG	1
Ariyawansa, J; Burton, PB; Moore, KT; Plotnikov, AN; Thyssen, A; Vaccaro, N	1
Andreas, JO; Braun, M; Cawello, W; Elshoff, JP	1

Reviews

1 review(s) available for omeprazole and thiophenes

Article	Year
An update on bimatoprost in glaucoma therapy. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amides; Antihypertensive Agents; Benzimidazoles; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Omeprazole; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes	2002

Article

Year

An update on bimatoprost in glaucoma therapy.

Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:12

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amides; Antihypertensive Agents; Benzimidazoles; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Omeprazole; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes

2002

Trials

1 trial(s) available for omeprazole and thiophenes

Article	Year
Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:6 Topics: Adolescent; Adult; Anticoagulants; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Omeprazole; Proton Pump Inhibitors; Rivaroxaban; Thiophenes; Young Adult	2011

Article

Year

Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban.

Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:6

Topics: Adolescent; Adult; Anticoagulants; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Omeprazole; Proton Pump Inhibitors; Rivaroxaban; Thiophenes; Young Adult

2011

Other Studies

6 other study(ies) available for omeprazole and thiophenes

Article	Year
Furan and thiophene analogues of omeprazole. Acta pharmaceutica Nordica, 1992, Volume: 4, Issue:4 Topics: Animals; Anti-Ulcer Agents; Furans; Gastric Acid; In Vitro Techniques; Male; Omeprazole; Rats; Thiophenes	1992
Gastric acid inhibitory profile of saviprazole (HOE 731) compared to omeprazole. Pharmacology, 1991, Volume: 43, Issue:6 Topics: Animals; Depression, Chemical; Dogs; Female; Gastric Acid; Imidazoles; Infusions, Intravenous; Ion Pumps; Male; Omeprazole; Perfusion; Protons; Rats; Rats, Inbred Strains; Thiophenes	1991
Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole. European journal of pharmacology, 1990, Oct-23, Volume: 187, Issue:3 Topics: Adenosine Triphosphatases; Animals; Dithioerythritol; Gastric Mucosa; Glutathione; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; Hydrogen; Imidazoles; In Vitro Techniques; Omeprazole; Papain; Piperazines; Proteins; Thiophenes	1990
New therapeutic agents marketed in 1995. Pennsylvania medicine, 1996, Volume: 99, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acarbose; Alendronate; Anti-Inflammatory Agents; Anti-Ulcer Agents; Carbonic Anhydrase Inhibitors; Drug Approval; Enzyme Inhibitors; Hypoglycemic Agents; Lansoprazole; Metformin; Omeprazole; Pregnadienes; Sulfonamides; Thiophenes; Trisaccharides; United States; United States Food and Drug Administration	1996
Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2007, Volume: 32, Issue:4-5 Topics: Administration, Oral; Alcohol Oxidoreductases; Animals; Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P450 Family 2; Cytochromes; Drug Interactions; Enzyme Inhibitors; Injections, Intravenous; Intestine, Small; Liver; Male; Membrane Proteins; Microsomes; Omeprazole; Pyrazines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiones; Thiophenes; Time Factors; Tissue Distribution	2007
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine. Clinical pharmacology in drug development, 2014, Volume: 3, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Area Under Curve; Biotransformation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Dopamine Agonists; Drug Interactions; Genotype; Healthy Volunteers; Humans; Male; Middle Aged; Omeprazole; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Proton Pump Inhibitors; South Africa; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Young Adult	2014